157318-92-8|SM 10906|Acetic acid, (2-(octahydro-5-hydroxy-4-(3-hydroxy-5-methyl-1-nonenyl)-2-pentalenyl)ethoxy)-, (2R-(2alpha,3aalpha,4alpha(1E,3S*,5S*),5beta,6aalpha))-|-范德生物科技公司

SM 10906

NMR下载 COA and HPLC MSDS下载
names：
Acetic acid, (2-(octahydro-5-hydroxy-4-(3-hydroxy-5-methyl-1-nonenyl)-2-pentalenyl)ethoxy)-, (2R-(2alpha,3aalpha,4alpha(1E,3S*,5S*),5beta,6aalpha))-
CAS号：
157318-92-8
MDL Number：
MF(分子式)： C22H38O5 MW(分子量)： 382.541
EINECS: Reaxys Number:
Pubchem ID: Brand:BIOFOUNT

货品编码	规格	纯度	价格 (¥)	现价(¥)	特价(¥)	库存描述	数量	总计 (¥)

大包装询价提供各种包装，敬请垂询
收藏商品商品点评加入购物车立即购买

快速询价

收起

你想询价的产品

*产品名称：

CAS号：

产品编号：

需求描述：

请准确填写您的联系方式，以便为您提供最好的服务。

*公司名称：

*电子邮箱：

联系人：

*电话：

*验证码：

询价

中文别名	Acetic acid, (2-(octahydro-5-hydroxy-4-(3-hydroxy-5-methyl-1-nonenyl)-2-pentalenyl)ethoxy)-, (2R-(2alpha,3aalpha,4alpha(1E,3S,5S),5beta,6aalpha))-
英文别名	SM 10906; SM10906; SM-10906
CAS号	157318-92-8
Inchi	InChI=1S/C22H38O5/c1-3-4-5-15(2)10-18(23)6-7-19-20-12-16(8-9-27-14-22(25)26)11-17(20)13-21(19)24/h6-7,15-21,23-24H,3-5,8-14H2,1-2H3,(H,25,26)/b7-6+/t15?,16-,17+,18-,19-,20+,21-/m1/s1
InchiKey	KCWJAXJEGXEZQC-XTWRSCCHSA-N
分子式 Formula	C22H38O5
分子量 Molecular Weight	382.541
溶解度Solubility
性状	Solid powder
储藏条件 Storage conditions	Dry, dark and store at 0-4℃ for short term (days to weeks) or -20℃ for long term (Store correctly 2-3years).

产品说明	SM 10906(CAS:157318-92-8):仅限应用于工业或者科学研究过程中非医疗目的，不应用于人类或动物的临床诊断以及治过程疗，该产品非药用，非食用。
Introduction	SM 10906 is a prostacyclin I1 (PGI1) analog.
Application1
Application2
Application3

警示图
危险性	Warning
危险性警示
安全声明
安全防护
备注

[1]Hiroi T, Maruyama K, Hattori K, Ohnuki T, Nagatomo T, Watanabe K, Yamamoto T, Hara Y. Affinity for [3H]iloprost binding sites and cAMP synthesis activity of a 3-oxa-methano prostaglandin I1 analog, SM-10906, in human platelets and endothelial cells. Jpn J Pharmacol. 1997 May;74(1):37-43. PubMed PMID: 9195295.

[2]Zhou LJ, Inoue M, Ono I, Kaneko F. The mode of action of prostaglandin (PG) I1 analog, SM-10906, on fibroblasts of hypertrophic scars is similar to PGE1 in its potential role of preventing scar formation. Exp Dermatol. 1997 Dec;6(6):314-20. PubMed PMID: 9412820.

[3] Nishimura T, Yamamoto T, Ueda Y, Yamada K, Hara Y. Stable prostaglandin I1 analog SM-10906 modulates productions of tumor necrosis factor-alpha, interleukin-1 and interleukin-6 in mouse macrophages. Biol Pharm Bull. 2000 Jun;23(6):708-11. PubMed PMID: 10864020.

[4] Kaneko F, Zhang JZ, Maruyama K, Nihei Y, Ono I, Iwatsuki K, Yamamoto T. Prostaglandin I1 analogues, SM-10902 and SM-10906, affect human keratinocytes and fibroblasts in vitro in a manner similar to PGE

[5] therapeutic potential for wound healing. Arch Dermatol Res. 1995;287(6):539-45. PubMed PMID: 7487139.

5: Nishimura T, Yamamoto T, Komuro Y, Hara Y. Antiplatelet functions of a stable prostacyclin analog, SM-10906 are exerted by its inhibitory effect on inositol 1,4,5-trisphosphate production and cytosolic Ca++ increase in rat platelets stimulated by thrombin. Thromb Res. 1995 Aug 1;79(3):307-17. PubMed PMID: 8533126.

对不起，暂无产品评价！

MSDS

SDS 1.0 中文

展开

SDS 1.0 英文

展开